PlainRecalls
FDA Devices Moderate Class II Terminated

Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBS

Reported: May 3, 2017 Initiated: March 17, 2017 #Z-1879-2017

Product Description

Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBSIs compared to the original ARROWg+ard Blue catheter has not been studied

Reason for Recall

Arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.

Details

Recalling Firm
Arrow International Inc
Units Affected
310 units
Distribution
US Distribution to NJ, IL, and PA
Location
Reading, PA

Frequently Asked Questions

What product was recalled?
Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBSIs compared to the original ARROWg+ard Blue catheter has not been studied. Recalled by Arrow International Inc. Units affected: 310 units.
Why was this product recalled?
Arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 3, 2017. Severity: Moderate. Recall number: Z-1879-2017.